CD8A and hepatocellular carcinoma: In addition, the tumor-suppressive effect of PCI-34051 was reported as T-cell-dependent and calcium-induced, increasing tumor-infiltrating CD8 T-cells in a preclinical model of hepatocellular carcinoma (HCC) [104].